Walgreens, local Chicago healthcare provider partner on 5,000 free flu shot vouchers for those in need
CHICAGO — To help improve flu immunization rates in underserved communities, Walgreens and Access Community Health Network on Tuesday announced a collaboration that will provide 5,000 free flu shot vouchers to Access to help those either without health insurance coverage or those unable to afford the vaccination to get their flu shot.
"By providing convenient access to flu shots at our stores, retail clinics and now, through flu clinics at select Access health centers, we are creating meaningful opportunities to help protect more people from influenza this flu season," stated Ron Weinert, Walgreens VP healthcare solutions. "This relationship with Access demonstrates the valuable role Walgreens pharmacists and Take Care Clinic nurse practitioners are playing in health care today, through coordinating care to improve patient outcomes and lower costs as part of a patient’s care team. It also underscores the importance of residents in our community being linked to a medical home."
Qualifying Access patients can receive a free flu shot voucher at any of Access’ 45 community health center locations throughout the Chicagoland area while supplies last. Vouchers are good for one flu shot at any Walgreens pharmacy or Take Care Clinic, available any day without an appointment and subject to the terms and conditions on the voucher.
New this year, Walgreens pharmacists will join Access at 24 on-site flu clinics at select Access health center locations throughout the area to help better meet the needs of Access patients.
Walgreens and Access have been working together for more than two years as part of a broader coordinated healthcare relationship to help improve community health and reduce the racial and ethnic health disparities in Chicagoland’s most vulnerable communities.
Beiersdorf appoints Bill Graham to president, GM Beiersdorf North America
WILTON, Conn. — Beiersdorf, the U.S. subsidiary of Beiersdorf AG — a global skin care company based in Hamburg, Germany — has announced the appointment of Bill Graham as president and general manager of Beiersdorf North America.
Graham previously served as president and general manager of Beiersdorf. His new role includes leadership of both the United States and Canadian business units. Graham was promoted to the position of general manager of Beiersdorf in August 2011, after joining the company as VP sales in 2007.
In his new role, Bill will focus on building a North American business strategy for the group’s core business, which includes the development of the Nivea, Eucerin and Aquaphor brands throughout North America. The general manager of Beiersdorf Canada, along with the Beiersdorf U.S. leadership team, will report to Graham. The North American management unit is located in the current Beiersdorf offices in Wilton, Conn.
“I’m confident that under Bill’s leadership, we will successfully execute our strategy and continue our collective commitment to accelerating positive profitable growth for our brands and businesses in both the United States and Canada,” stated Peter Feld, executive board member.
Merck to move HQ in New Jersey
WHITEHOUSE STATION, N.J. — Merck is moving its global headquarters from Whitehouse Station, N.J., to its existing property in Summit, N.J., which currently houses research, manufacturing, animal health and consumer care operations.
The drug maker said about 2,000 employees and contractors currently situated at the Whitehouse Station global headquarters building — which has been home for the company since 1992 after moving from Rahway, N.J. — either will move to the new facilities in Summit or to other nearby facilities, such as those in Branchburg, N.J. and Cokesbury, N.J.
The headquarters relocation is part of the company’s ongoing program to consolidate its global real estate footprint and lower its annual operating expenses, following its merger with Schering-Plough in 2009. The transition process is expected to begin in 2014 and be completed in mid-2015.
"The relocation of our headquarters will help us achieve our future vision, reduce the size of our operating footprint, and increase agility as we adapt to our changing business environment," Merck chairman and CEO Kenneth Frazier said.